Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer
Daniele Generali(University of Trieste), Alfredo Berruti(Surgical Specialties (Canada)), Federica Vergoni(Istituti Ospitalieri di Cremona), Alessandra Bersiga(Istituti Ospitalieri di Cremona), Giovanni Allevi(Istituti Ospitalieri di Cremona), Rossana Dionisio(John Radcliffe Hospital), Maria Pia Brizzi(Ospedale San Luigi Gonzaga), Sergio Aguggini(Istituti Ospitalieri di Cremona), Luigi Dogliotti(Aarhus University Hospital), Roberto Giardini(Fondazione IRCCS Istituto Nazionale dei Tumori), Adrian L. Harris(University of Oxford), Stephen B. Fox(Peter MacCallum Cancer Centre), Manuela Milani(Humanitas University), Simone Bonardi(Istituti Ospitalieri di Cremona), Leticia Campo(University of Oxford), Alberto Bottini(University of Genoa)
Cited by 55
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k